相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Approach to Hypertension in Adolescents and Young Adults
Seyed Mehrdad Hamrahian et al.
CURRENT CARDIOLOGY REPORTS (2022)
Isolated Diastolic Hypertension and Risk of Cardiovascular Events: A Systematic Review and Meta-Analysis of Cohort Studies With 489,814 Participants
Mingyan Huang et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)
Rosuvastatin and ezetimibe for the treatment of dyslipidemia and hypercholesterolemia
Chrysoula Boutari et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2021)
Combination of bempedoic acid, ezetimibe, and atorvastatin in patients with hypercholesterolemia: A randomized clinical trial
John Rubino et al.
ATHEROSCLEROSIS (2021)
Antihypertensive Medication Classes and the Risk of Dementia: A Systematic Review and Network Meta-Analysis
Melina G. H. E. den Brok et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2021)
Polypill with or without Aspirin in Persons without Cardiovascular Disease
S. Yusuf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Beneficial Effects of a Perindopril/Indapamide Single-Pill Combination in Hypertensive Patients with Diabetes and/or Obesity or Metabolic Syndrome: A Post Hoc Pooled Analysis of Four Observational Studies
Csaba Farsang et al.
ADVANCES IN THERAPY (2021)
Chlorthalidone for Hypertension in Advanced Chronic Kidney Disease
Rajiv Agarwal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Torasemide in Hypertension and Heart Failure: Re-inventing Loop Diuretic Therapy?
Athanasios Manolis et al.
CURRENT PHARMACEUTICAL DESIGN (2021)
Long-Term Impact of Different Triple Combination Antihypertensive Medications on Blood Pressure Control, Metabolic Pattern and Incident Events: Data from the Brisighella Heart Study
Arrigo F. G. Cicero et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Calcium Channel Blockers Are Associated with Nocturia in Men Aged 40 Years or Older
Satoshi Washino et al.
JOURNAL OF CLINICAL MEDICINE (2021)
The Number of Pills, Rather Than the Type of Renin-Angiotensin System Inhibitor, Predicts Ambulatory Blood Pressure Control in Essential Hypertensives on Triple Therapy: A Real-Life Cross-Sectional Study
Riccardo Sarzani et al.
ADVANCES IN THERAPY (2021)
Adherence to Lipid-Lowering Treatment by Single-Pill Combination of Statin and Ezetimibe
Federico Rea et al.
ADVANCES IN THERAPY (2021)
Effects of Fixed-dose Combination of Low-intensity Rosuvastatin and Ezetimibe Versus Moderate- intensity Rosuvastatin Monotherapy on Lipid Profiles in Patients With Hypercholesterolemia: A Randomized, Double-blind, Multicenter, Phase III Study
Seung-Ah Lee et al.
CLINICAL THERAPEUTICS (2021)
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC)
Frank L. J. Visseren et al.
EUROPEAN HEART JOURNAL (2021)
Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
Antonio J. Vallejo-Vaz et al.
LANCET (2021)
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension
Weili Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy
Christie M. Ballantyne et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2020)
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Francois Mach et al.
EUROPEAN HEART JOURNAL (2020)
Statin therapy is associated with better ambulatory blood pressure control: a propensity score analysis
Francesco Spannella et al.
JOURNAL OF HYPERTENSION (2020)
Hypertension in older adults: Assessment, management, and challenges
Estefania Oliveros et al.
CLINICAL CARDIOLOGY (2020)
Investigation and Treatment of High Blood Pressure in Young People Too Much Medicine or Appropriate Risk Reduction?
Thomas C. Hinton et al.
HYPERTENSION (2020)
A randomized, double-blind clinical trial to evaluate the efficacy and safety of a fixed-dose combination of amlodipine/rosuvastatin in patients with dyslipidemia and hypertension
Woohyeun Kim et al.
JOURNAL OF CLINICAL HYPERTENSION (2020)
Nutraceuticals and blood pressure control: a European Society of Hypertension position document
Claudio Borghi et al.
JOURNAL OF HYPERTENSION (2020)
A practical approach to switch from a multiple pill therapeutic strategy to a polypill-based strategy for cardiovascular prevention in patients with hypertension
Antonio Coca et al.
JOURNAL OF HYPERTENSION (2020)
Awareness of major cardiovascular risk factors and its relationship with markers of vascular aging: Data from the Brisighella Heart Study
Arrigo F. G. Cicero et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2020)
Sodium-glucose co-transporter-2 inhibitors: peculiar hybrid diuretics that protect from target organ damage and cardiovascular events
Riccardo Sarzani et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2020)
Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration
Gian Paolo Fadini et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2020)
Evaluation of Aspirin and Statin Therapy Use and Adherence in Patients With Premature Atherosclerotic Cardiovascular Disease
Dhruv Mahtta et al.
JAMA NETWORK OPEN (2020)
Association of Glomerular Hyperfiltration and Cardiovascular Risk in Middle-Aged Healthy Individuals
Marie-Eve Dupuis et al.
JAMA NETWORK OPEN (2020)
Single Pill Regimen Leads to Better Adherence and Clinical Outcome in Daily Practice in Patients Suffering from Hypertension and/or Dyslipidemia: Results of a Meta-Analysis
Burkhard Weisser et al.
HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION (2020)
Antihypertensive Effectiveness of Perindopril Arginine and Indapamide Single-Pill Combination According to Body Mass Index: Findings from the FORSAGE Study
M. G. Glezer
CARDIOLOGY AND THERAPY (2020)
Evaluating the efficacy and safety of atorvastatin plus ezetimibe in a fixed-dose combination for the treatment of hypercholesterolemia
Ya-Bin Ma et al.
EXPERT OPINION ON PHARMACOTHERAPY (2019)
Prevalence and Control of Dyslipidemia in Patients Referred for High Blood Pressure: The Disregarded Double-Trouble Lipid Profile in Overweight/Obese
Francesco Spannella et al.
ADVANCES IN THERAPY (2019)
Achievement of low density lipoprotein (LDL) cholesterol targets in primary and secondary prevention: Analysis of a large real practice database in Italy
Vivianne Presta et al.
ATHEROSCLEROSIS (2019)
Alpha-Blocker Use and the Risk of Hypotension and Hypotension-Related Clinical Events in Women of Advanced Age
Swapnil Hiremath et al.
HYPERTENSION (2019)
Pulse Pressure, Cardiovascular Events, and Intensive mood-Pressure Lowering in the Systolic Blood Pressure Intervention Trial (SPRINT)
Manan Pareek et al.
AMERICAN JOURNAL OF MEDICINE (2019)
Comparative Analysis of Long-Term Outcomes of Torasemide and Furosemide in Heart Failure Patients in Heart Failure Registries of the European Society of Cardiology
Krzysztof Ozieranski et al.
CARDIOVASCULAR DRUGS AND THERAPY (2019)
Efficacy and Safety of Incremental Dosing of a New Single-Pill Formulation of Perindopril and Amlodipine in the Management of Hypertension
Neil R. Poulter et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2019)
Nutrients and Nutraceuticals for the Management of High Normal Blood Pressure: An Evidence-Based Consensus Document
Arrigo F. G. Cicero et al.
HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION (2019)
Orthostatic Hypotension in the Hypertensive Patient
Italo Biaggioni
AMERICAN JOURNAL OF HYPERTENSION (2018)
Achievement of multiple therapeutic targets for cardiovascular disease prevention: Retrospective analysis of real practice in Italy
Ilaria Figliuzzi et al.
CLINICAL CARDIOLOGY (2018)
Ten-year changes in ambulatory blood pressure: The prognostic value of ambulatory pulse pressure
Paolo Balietti et al.
JOURNAL OF CLINICAL HYPERTENSION (2018)
A Bayesian network meta-analysis of PCSK9 inhibitors, statins and ezetimibe with or without statins for cardiovascular outcomes
Safi U. Khan et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2018)
Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies
Bryan Williams et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
2018 ESC/ESH Guidelines for the management of arterial hypertension
Bryan Williams et al.
EUROPEAN HEART JOURNAL (2018)
Long-term mortality after blood pressure-lowering and lipid-lowering treatment in patients with hypertension in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Legacy study: 16-year follow-up results of a randomised factorial trial
Ajay Gupta et al.
LANCET (2018)
2018 Practice Guidelines for the management of arterial hypertension of the European Society of Cardiology andthe European Society of Hypertension ESC/ESH Task Force for the Management of Arterial Hypertension
Bryan Williams et al.
JOURNAL OF HYPERTENSION (2018)
Influence of fixed-dose combination perindopril/amlodipine on target organ damage in patients with arterial hypertension with and without ischemic heart disease (results of EPHES trial)
Ganna D. Radchenko et al.
VASCULAR HEALTH AND RISK MANAGEMENT (2018)
Orthostatic Hypotension in the Hypertensive Patient
Italo Biaggioni
AMERICAN JOURNAL OF HYPERTENSION (2018)
Is it Possible to Significantly Modify Blood Pressure with a Combined Nutraceutical on Top of a Healthy Diet? The Results of a Pilot Clinical Trial
Arrigo F. G. Cicero et al.
HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION (2018)
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
Brian A. Ference et al.
EUROPEAN HEART JOURNAL (2017)
Lower dementia risk with different classes of antihypertensive medication in older patients
Tessa van Middelaar et al.
JOURNAL OF HYPERTENSION (2017)
The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension
Christopher H. Gibbons et al.
JOURNAL OF NEUROLOGY (2017)
Association Between More Intensive vs Less Intensive Blood Pressure Lowering and Risk of Mortality in Chronic Kidney Disease Stages 3 to 5 A Systematic Review and Meta-analysis
Rakesh Malhotra et al.
JAMA INTERNAL MEDICINE (2017)
Current Situation of Medication Adherence in Hypertension
Bernard Vrijens et al.
FRONTIERS IN PHARMACOLOGY (2017)
The polypill approach - An innovative strategy to improve cardiovascular health in Europe
Valentin Fuster et al.
BMC PHARMACOLOGY & TOXICOLOGY (2017)
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN)
Maurizio Averna et al.
ATHEROSCLEROSIS SUPPLEMENTS (2017)
Fixed-Dose Triple Combination of Antihypertensive Drugs Improves Blood Pressure Control: From Clinical Trials to Clinical Practice
Alberto Mazza et al.
ADVANCES IN THERAPY (2017)
Isolated Systolic Hypertension: An Update After SPRINT
Chirag Bavishi et al.
AMERICAN JOURNAL OF MEDICINE (2016)
Effect of fixed-dose combinations of ezetimibe plus rosuvastatin in patients with primary hypercholesterolemia: MRS-ROZE (Multicenter Randomized Study of ROsuvastatin and eZEtimibe)
Kyung-Jin Kim et al.
CARDIOVASCULAR THERAPEUTICS (2016)
An Expert Opinion From the European Society of Hypertension-European Union Geriatric Medicine Society Working Group on the Management of Hypertension in Very Old, Frail Subjects
Athanase Benetos et al.
HYPERTENSION (2016)
Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years A Randomized Clinical Trial
Jeff D. Williamson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Comparative study of the efficacy of olmesartan/amlodipine vs. perindopril/amlodipine in peripheral blood pressure after missed dose in type 2 diabetes
Josep Redon et al.
JOURNAL OF HYPERTENSION (2016)
Hydrochlorothiazide as the Diuretic of Choice for Hypertension Time to Kick the Habit
Hillel Sternlicht et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Efficacy of Low-Dose Chlorthalidone and Hydrochlorothiazide as Assessed by 24-h Ambulatory Blood Pressure Monitoring
Anil K. Pareek et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
Dena Ettehad et al.
LANCET (2016)
Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease
Salim Yusuf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
NT-proBNP and Its Correlation with In-Hospital Mortality in the Very Elderly without an Admission Diagnosis of Heart Failure
Riccardo Sarzani et al.
PLOS ONE (2016)
Blood Pressure and Risk of Vascular Dementia Evidence From a Primary Care Registry and a Cohort Study of Transient Ischemic Attack and Stroke
Connor A. Emdin et al.
STROKE (2016)
Perindopril and β-blocker for the prevention of cardiac events and mortality in stable coronary artery disease patients: A EUropean trial on Reduction Of cardiac events with Perindopril in stable coronary Artery disease (EUROPA) subanalysis
Michel E. Bertrand et al.
AMERICAN HEART JOURNAL (2015)
Hypercholesterolemia and Hypertension: Two Sides of the Same Coin
Branislava Ivanovic et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2015)
Familial Hypercholesterolemia
Victoria Enchia Bouhairie et al.
CARDIOLOGY CLINICS (2015)
Associations Between Body Mass Index, Ambulatory Blood Pressure Findings, and Changes in Cardiac Structure: Relevance of Pulse and Nighttime Pressures
Massimiliano Fedecostante et al.
JOURNAL OF CLINICAL HYPERTENSION (2015)
Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention The Multicenter Randomized Controlled PRECISE-IVUS Trial
Kenichi Tsujita et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Isolated Systolic Hypertension in Young and Middle-Aged Adults and 31-Year Risk for Cardiovascular Mortality The Chicago Heart Association Detection Project in Industry Study
Yuichiro Yano et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
Christopher P. Cannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Comparison of olmesartan combined with a calcium channel blocker or a diuretic in elderly hypertensive patients (COLM Study): safety and tolerability
Takao Saruta et al.
HYPERTENSION RESEARCH (2015)
Efficacy and Tolerability of Fixed-Dose Combination of Perindopril/Indapamide in Type 2 Diabetes Mellitus: PICASSO Trial
Csaba Farsang
ADVANCES IN THERAPY (2014)
Antihypertensive Efficacy of Triple Combination Perindopril/Indapamide Plus Amlodipine in High-Risk Hypertensives: Results of the PIANIST Study (Perindopril-Indapamide plus AmlodipiNe in high rISk hyperTensive patients)
Kalman Toth
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2014)
Triple Combination Therapy in Hypertension: The Antihypertensive Efficacy of Treatment with Perindopril, Amlodipine, and Indapamide SR
Denes Pall et al.
CLINICAL DRUG INVESTIGATION (2014)
Excess dietary sodium and inadequate potassium intake by hypertensive patients in Italy: results of the MINISAL-SIIA study program
Ferruccio Galletti et al.
JOURNAL OF HYPERTENSION (2014)
A Polypill Strategy to Improve Adherence Results From the FOCUS Project
Jose M. Castellano et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Follow-up of Blood-Pressure Lowering and Glucose Control in Type 2 Diabetes
S. Zoungas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Chronic Kidney Disease Is Characterized by Double Trouble Higher Pulse Pressure plus Night-Time Systolic Blood Pressure and More Severe Cardiac Damage
Massimiliano Fedecostante et al.
PLOS ONE (2014)
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
Walter N. Kernan et al.
STROKE (2014)
Renoprotective Effect of Renin-Angiotensin-Aldosterone System Blockade in Patients With Predialysis Advanced Chronic Kidney Disease, Hypertension, and Anemia
Ta-Wei Hsu et al.
JAMA INTERNAL MEDICINE (2014)
Hypertensive Heart Disease and Obesity: A Complex Interaction Between Hemodynamic and Not Hemodynamic Factors
Riccardo Sarzani et al.
HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION (2014)
Valsartan/Amlodipine Compared to Nifedipine GITS in Patients with Hypertension Inadequately Controlled by Monotherapy
Ji-Guang Wang et al.
ADVANCES IN THERAPY (2013)
Comparative effectiveness of angiotensin-receptor blockers for preventing macrovascular disease in patients with diabetes: a population-based cohort study
Tony Antoniou et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2013)
Twenty-Four-Hour Ambulatory Blood Pressure Reduction with a Perindopril/Amlodipine Fixed-Dose Combination
Viktor L. Nagy
CLINICAL DRUG INVESTIGATION (2013)
Antihypertensive classes, cognitive decline and incidence of dementia: a network meta-analysis
Natacha Levi Marpillat et al.
JOURNAL OF HYPERTENSION (2013)
Treatment of Arterial Hypertension in Obese Patients
Ulrich O. Wenzel et al.
SEMINARS IN NEPHROLOGY (2013)
2012 Consensus Document of the Italian Society of Hypertension (SIIA): Strategies to Improve Blood Pressure Control in Italy From Global Cardiovascular Risk Stratification to Combination Therapy
Massimo Volpe et al.
HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION (2013)
Circadian Rhythms in Blood Pressure Regulation and Optimization of Hytertension Treatment With ACE Inhibitor and ARB Medications
Ramon C. Hermida et al.
AMERICAN JOURNAL OF HYPERTENSION (2011)
Impact of amlodipine-based therapy among older and younger patients in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA)
David J. Collier et al.
JOURNAL OF HYPERTENSION (2011)
Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey
Salim Yusuf et al.
LANCET (2011)
The Association of Left Ventricular Hypertrophy with Metabolic Syndrome is Dependent on Body Mass Index in Hypertensive Overweight or Obese Patients
Federico Guerra et al.
PLOS ONE (2011)
Olmesartan/amlodipine: a review of its use in the management of hypertension
R. Kreutz
VASCULAR HEALTH AND RISK MANAGEMENT (2011)
Benefits of once-daily therapies in the treatment of hypertension
John M. Flack et al.
VASCULAR HEALTH AND RISK MANAGEMENT (2011)
Obesity-Related Hypertension: Epidemiology, Pathophysiology, and Clinical Management
Theodore A. Kotchen
AMERICAN JOURNAL OF HYPERTENSION (2010)
Triple Therapy With Olmesartan Medoxomil, Amlodipine Besylate, and Hydrochlorothiazide in Adult Patients With Hypertension: The TRINITY Multicenter, Randomized, Double-Blind, 12-Week, Parallel-Group Study
Suzanne Oparil et al.
CLINICAL THERAPEUTICS (2010)
Fixed-dose combination and chronic kidney disease progression: which is the best?
Keith A. Hopkins et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2010)
Combination Therapy Versus Monotherapy in Reducing Blood Pressure: Meta-analysis on 11,000 Participants from 42 Trials
David S. Wald et al.
AMERICAN JOURNAL OF MEDICINE (2009)
Adherence to Antihypertensive Medications and Cardiovascular Morbidity Among Newly Diagnosed Hypertensive Patients
Giampiero Mazzaglia et al.
CIRCULATION (2009)
The combination of olmesartan medoxomil and Amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study
Steven G. Chrysant et al.
CLINICAL THERAPEUTICS (2008)
Effects of a fixed-dose ACE inhibitor-diuretic combination on ambulatory blood pressure and arterial properties in isolated systolic hypertension
Joanne M. Ferguson et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2008)
Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans
Riccardo Sarzani et al.
JOURNAL OF HYPERTENSION (2008)
Treatment of hypertension in patients 80 years of age or older
Nigel S. Beckett et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
Anushka Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Losartan: lessons learned from the RENAAL study
S Shahinfar et al.
EXPERT OPINION ON PHARMACOTHERAPY (2006)
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes - Principal results of the Conduit Artery Function Evaluation (CAFE) study
B Williams et al.
CIRCULATION (2006)
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA):: a multicentre randomised controlled trial
B Dahlöf et al.
LANCET (2005)
Drug therapy - Adherence to medication
L Osterberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
ESC Study Group of Sports Cardiology Recommendations for participation in leisure-time physical activities and competitive sports for patients with hypertension
RH Fagard et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION (2005)
Mechanisms, pathophysiology, and therapy of arterial stiffness
SJ Zieman et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
S Yusuf et al.
LANCET (2004)
Pathophysiology and treatment of obesity hypertension
MR Wofford et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history - The PROGRESS trial
N Chapman et al.
STROKE (2004)
Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled
P Bramlage et al.
AMERICAN JOURNAL OF HYPERTENSION (2004)
Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials
MR Law et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA):: a multicentre randomised controlled trial
PS Sever et al.
LANCET (2003)
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
EJ Lewis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
HH Parving et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
